申请人:Janssen Pharmaceutica NV
公开号:US08193178B2
公开(公告)日:2012-06-05
Thieno- and furo-pyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the modulation of histamine H4 receptor activity and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as inflammation.
本文描述了一类噻吩和呋喃嘧啶化合物,可用作H4受体调节剂。这些化合物可用于制备药物组合物,并用于调节组胺H4受体活性和治疗由H4受体活性介导的疾病状态、障碍和病况,如炎症等的方法。